Global Clinical Development
We manage Phase I–IV trials across 50+ countries with a risk-based monitoring approach — central data review, triggered on-site visits, and real-time CTMS visibility for sponsors. Our CRAs are direct employees, not contractors, and site selection is driven by our own feasibility database built from 20+ years of Bright Pharmaceutical Services site relationships. Hybrid and decentralized models are fully supported, including home health and e-consent workflows.
Phase I–IVRisk-Based MonitoringSite Selection & FeasibilityDecentralized / DCT
Regulatory & Quality
IND, CTA, and IDE preparation for FDA, EMA, Health Canada, PMDA, and NMPA. Our regulatory team has prepared Type A, B, and C meeting packages and represented sponsors in formal agency interactions. eCTD publishing is handled in-house. Our QMS is built on ICH-GCP, ICH E6(R2), and ICH Q10 frameworks, and our teams are prepared for FDA, EMA, and MHRA inspections from day one.
IND / CTA / IDEFDA / EMA / PMDAAgency MeetingseCTDICH-GCP
Biometrics & Data Sciences
Statistical analysis plan development, CDISC-compliant SDTM and ADaM datasets, and submission-ready statistical packages. We select EDC, ePRO, and data management platforms based on your program, budget, and size — not our preferred vendor relationship. Medical coding uses MedDRA and WHO Drug. Electronic submission-ready datasets are standard, not an upgrade.
SDTM / ADaMSAP DevelopmentMedDRA / WHO DrugePROVendor-Agnostic
Safety & Pharmacovigilance
Individual case processing (CIOMS-I, MedWatch, SUSAR), aggregate reporting (DSUR, IND annual report, PBRER), and ongoing signal detection. We manage safety databases in both Argus and ArisG depending on sponsor preference. Our safety team operates 24/7 for case intake and is staffed by medical monitors with clinical and regulatory backgrounds.
CIOMS-I / MedWatchDSUR / IND Annual ReportArgus / ArisGSignal Detection
Clinical Supply & Logistics
IRT/RTSM integration, comparator sourcing, labeling and packaging for international shipments, and cold-chain management including direct-to-patient depots. We select IRT/RTSM vendors based on your program's complexity and budget — the right tool for the job, not the most expensive one. Our Texas-based supply operations simplify import/export for CPRIT-funded programs requiring U.S.-based chain of custody documentation.
IRT / RTSMComparator SourcingCold ChainDirect-to-Patient